Consensus Cloud Solutions Q2 2026 Earnings: Corporate Revenue Hits Record as Healthcare Strategy Takes Shape
Consensus Cloud Solutions (NASDAQ:CCSI) delivered second-quarter 2026 results that underscored a familiar split: the corporate fax business is still growing, while the company’s smaller SoHo unit continues to fade. At the same time, management laid out a more defined strategy for turning its healthcare customer base into a long-term workflow software opportunity.
The company posted consolidated revenue of $91.4 million, up 4.1% from the prior-year period, and said it was the third straight quarter of year-over-year growth across revenue, adjusted EBITDA, adjusted non-GAAP EPS and free cash flow. Adjusted EBITDA rose 0.5% to $48.3 million, while adjusted net income increased 0.7% to $28.7 million. Adjusted EPS advanced 2.1% to $1.49, helped in part by a lower share count from repurchases. Adjusted EBITDA margin came in at 52.9%, within management’s target range of 50% to 55%.
The corporate channel, which is the strategic core of the company, generated a record $60.5 million in quarterly revenue, up 9.3% year over year and 3% sequentially. CEO Scott Turicchi said growth was supported by strong usage, revenue retention, new customer additions and contributions from advanced products. Corporate customers totaled roughly 67,000 at quarter-end, up 9.4% from a year earlier. Corporate average revenue per account rose about 1% to $305, while trailing-12-month net revenue retention improved to 103.1% from 102% in the prior quarter.
Chief Revenue Officer Johnny Hecker said secure cloud fax remains the company’s principal source of dollar growth. He pointed to regulated industries such as healthcare and the public sector, which are still moving away from legacy on-premise fax servers. “We're winning new customers, our existing customers' traffic is growing, and we're capturing larger shares of wallet within those established accounts,” Hecker said.
The SoHo channel, managed primarily for cash generation and contribution margin, posted revenue of $30.9 million, down 4.7% year over year. That was an improvement from a 9.5% decline in the first quarter. Management said it expects SoHo revenue to decline between 5% and 7% in each of the next two quarters and reiterated that it will not chase lower-margin volume just to support subscriber metrics.
One of the clearest strategic moves this quarter was the creation of a Healthcare Strategy and Solutions Group, led by newly appointed Chief Healthcare Solutions Officer Steve Tolle. The group is responsible for the company’s healthcare product portfolio, go-to-market efforts and strategy for primarily non-fax solutions. Turicchi said the unit will focus on converting unstructured healthcare documents, such as faxed referrals, authorizations, orders and record requests, into structured data that can move through clinical workflows. The idea is to give existing eFax customers a path into higher-value services while also attracting clients that want workflow intelligence rather than just document transport.
Consensus also completed a tuck-in acquisition of doc.health, a workflow platform for clinically adjacent functions including referral management, care coordination, patient follow-up and administrative tasks between visits. The deal brought in 14 doc.health employees, along with its customer base, pipeline and technology. Management expects to keep hiring in the healthcare unit through 2027 and said the group should make meaningful contributions to non-fax revenue starting in 2028.
During the question-and-answer session, Hecker said hospitals are taking a more deliberate approach to vendor selection and putting greater emphasis on electronic health record integrations and return on investment. Consensus is leaning into ROI in customer discussions and benefits from integrations with multiple EHR providers and partnerships in the sector.
On the public-sector side, the Department of Veterans Affairs remains a major customer. The VA issued a policy in late first quarter requiring ECFax, powered by eFax, as its secure fax solution. Hecker estimated the rollout is roughly 65% to 80% complete, though he cautioned that site count does not directly translate into volume because usage varies by location. Consensus expects VA revenue to exceed $9 million in 2026 and said the policy is also opening the door with government contractors, suppliers and other agencies, though larger public-sector implementations may take time to develop and scale.
Turicchi said continued usage growth among existing customers, public-sector expansion and newly secured customer wins could support corporate revenue growth moving into double digits, assuming no major change in economic conditions.
Cash flow remains a point of strength. Free cash flow rose about 25% year over year to $25.5 million, helped by receivables management and lower interest expense. The company ended the quarter with roughly $99 million in cash, up $6.6 million from the first quarter, and maintained its expectation for about $106 million in full-year free cash flow.
Consensus repurchased about 300,000 shares for approximately $9.6 million during the quarter, and its board expanded the overall share-repurchase authorization to $200 million. The company has spent about $82 million to buy 3 million shares under the program, leaving about $118 million available. Total debt stood at approximately $558 million at quarter-end, including $348 million of 6.5% high-yield notes, $146 million in term-loan borrowings and $64 million on its revolver. Net debt to EBITDA was 2.45 times.
Looking ahead, management said full-year revenue should land between the midpoint and high end of its outlook, while adjusted EBITDA and adjusted EPS are expected to run slightly above their respective midpoints. The doc.health acquisition is expected to add about $1 million of full-year revenue, reduce adjusted EBITDA by roughly $0.6 million and lower adjusted EPS by approximately $0.02.
For investors, the quarter frames Consensus as a company still anchored by secure fax but increasingly intent on repositioning itself as a healthcare workflow technology provider. The doc.health deal and the new healthcare unit are early tests of that transition. With non-fax revenue contributions not expected until 2028, the immediate focus will remain on sustaining corporate growth while funding the broader push into healthcare automation.